Venous or arterial samples for activated clotting time measurements: a systematic review

被引:1
|
作者
Iddawela, Sashini [1 ]
Swamy, Priti [2 ]
Member, Sajid [3 ]
Harky, Amer [4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Birmingham, Dept Resp Med, Birmingham, W Midlands, England
[2] Kings Coll London, GKT Sch Med Educ, London, England
[3] Univ Cent Lancashire, Lancashire Sch Med & Dent, Greenbank Bldg, Preston, Lancs, England
[4] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[5] Univ Liverpool, Fac Hlth & Iife Sci, Dept Integrat Biol, Liverpool, Merseyside, England
[6] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[7] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[8] Alder Hey Children Hosp, Dept Cardiac Surg, Liverpool, Merseyside, England
来源
PERFUSION-UK | 2021年 / 36卷 / 08期
关键词
clotting factors; ACT; venous; arterial; cardiac surgery; cardiac catheterisation; COAGULATION TIME; HEPARIN; THROMBOELASTOGRAPHY; SURGERY;
D O I
10.1177/0267659120967836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The systematic review aims to investigate the effect of sampling source on activated clotting time (ACT) measurement within cardiovascular surgery and cardiac catheterisation. It also examines the evidence surrounding novel clot assessment techniques and associated sampling variation. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar until 20th June 2020. All studies reporting sampling source variability of ACT in cardiac surgery, vascular surgery and cardiac catheterisation were included. Results: Fourteen studies were included in the systematic review. Inconsistent reports of variability were seen in cardiac surgery and cardiac catheterisation. There were no studies directly examining ACT variability in vascular surgery. Novel clot assessment techniques have been validated in cardiac surgery, but measurements vary depending on sampling source. Conclusion: Sampling source should be kept consistent to facilitate effective haemostatic strategies. More research is needed regarding variability in vascular surgery and novel clot assessment techniques.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 50 条
  • [41] Relation between activated clotting time during angioplasty and abrupt closure
    Narins, CR
    Hillegass, WB
    Nelson, CL
    Tcheng, JE
    Harrington, RA
    Phillips, HR
    Stack, RS
    Califf, RM
    CIRCULATION, 1996, 93 (04) : 667 - 671
  • [42] The role of the activated clotting time (ACT) in anticoagulation assessment after PTCA
    Kunert, M
    Sorgenicht, R
    Scheuble, L
    Ketteler, T
    Lurken, E
    Meyer, I
    Muller, A
    Emmerich, K
    Gulker, H
    ZEITSCHRIFT FUR KARDIOLOGIE, 1996, 85 (02): : 118 - 124
  • [43] Activated clotting time value as an independent predictor of postoperative bleeding and transfusion
    Pereira, Rafael Manies
    Magueijo, Diogo
    Guerra, Nuno Carvalho
    Correia, Catarina Jacinto
    Rodrigues, Anabela
    Nobre, Angelo
    Brito, Dulce
    Moita, Luis Ferreira
    Velho, Tiago R.
    INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 2024, 38 (05):
  • [44] Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients
    Atallah, S.
    Liebl, M.
    Fitousis, K.
    Bostan, F.
    Masud, F.
    PERFUSION-UK, 2014, 29 (05): : 456 - 461
  • [45] Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass
    Gautam, Nischal K.
    Schmitz, Michael L.
    Harrison, Dale
    Zabala, Luis M.
    Killebrew, Pamela
    Belcher, Ryan H.
    Prodhan, Parthak
    Mckamie, Wesley
    Norvell, Daniel C.
    PEDIATRIC ANESTHESIA, 2013, 23 (03) : 233 - 241
  • [46] Factor XII deficiency and cardiopulmonary bypass: Use of a novel modification of the activated clotting time to monitor anticoagulation
    Gerhardt, MA
    Greenberg, CS
    Slaughter, TF
    Smith, MS
    ANESTHESIOLOGY, 1997, 87 (04) : 990 - 992
  • [47] ACTIVATED CLOTTING TIME AS AN APPROPRIATE TEST TO COMPARE HEPARIN AND DIRECT THROMBIN INHIBITORS SUCH AS HIRUDIN OR RO-46-6240 IN EXPERIMENTAL ARTERIAL THROMBOSIS
    CARTEAUX, JP
    GAST, A
    TSCHOPP, TB
    ROUX, S
    CIRCULATION, 1995, 91 (05) : 1568 - 1574
  • [48] Laboratory Assessment of Unfractionated Heparin (UFH) with Activated Clotting Time (ACT) and Anti-Xa Activity during Peripheral Arterial Angiographic Procedure
    Helin, Tuukka
    Tirri, Tomi
    Korkala, Heidi
    Lappalainen, Kimmo
    Joutsi-Korhonen, Lotta
    DIAGNOSTICS, 2023, 13 (08)
  • [49] AN EVALUATION OF 2 ACTIVATED CLOTTING TIME MONITORS DURING CARDIAC-SURGERY
    REICH, DL
    ZAHL, K
    PERUCHO, MH
    THYS, DM
    JOURNAL OF CLINICAL MONITORING, 1992, 8 (01): : 33 - 36
  • [50] Anticoagulation control with ACT (activated clotting time) during interventional neuroradiology.
    Berlis, A
    Schumacher, M
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 1999, 170 (04): : 378 - 383